This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Global Loan Agency Services Gmbh, Resolve Biosciences Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Andreas Geipel
Introduction
Andreas Geipel is a notable inventor based in Mettmann, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for detecting various analytes in samples. His work has implications for diagnostics and drug testing, showcasing the intersection of technology and healthcare.
Latest Patents
Geipel holds a patent for a "Multiplex method for detecting different analytes in a sample." This innovative technology relates to multiplex methods and kits designed for the detection of different analytes and their variations in a sample. The patent outlines in vitro methods for screening, identifying, and testing substances or drugs, as well as for diagnosing diseases. This optical multiplexing system represents a significant advancement in the field.
Career Highlights
Andreas Geipel is associated with Resolve Biosciences GmbH, where he continues to push the boundaries of scientific research and innovation. His work at the company emphasizes the importance of developing efficient and effective diagnostic tools that can improve patient outcomes.
Collaborations
Geipel collaborates with talented professionals in his field, including Christian Korfhage and Frank Reinecke. These partnerships enhance the research and development efforts at Resolve Biosciences GmbH, fostering an environment of innovation.
Conclusion
Andreas Geipel's contributions to biotechnology through his patent and work at Resolve Biosciences GmbH highlight the importance of innovation in healthcare. His advancements in multiplex detection methods are paving the way for improved diagnostic capabilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile